Phyllocladene

Phyllocladene

SCHEMBL20538769

C=C1C[C@@]23CC[C@@H]4C(C)(C)CCC[C@@]4(C)[C@@H]2CC[C@@H]1C3.O=P(O)(O)OP(=O)(O)O

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.65
HSD11B1 P28845 4/20 0.61
HSD11B2 P80365 1/20 0.61
BCHE P06276 1/20 0.40
ACHE P22303 1/20 0.40
ATM Q13315 1/20 0.37
PTPN2 P17706 2/20 0.36
F10 P00742 4/20 0.35
CDC25B P30305 1/20 0.35
ALDH1A1 P00352 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
TSHR P16473 1/20 0.35
CYP2C19 P33261 1/20 0.35
RPS6KA5 O75582 1/20 0.35
MAPKAPK2 P49137 1/20 0.35
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
KMT2A Q03164 1/20 0.34
PAX8 Q06710 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phyllocladene SCHEMBL16414456 1.00 PTPN1 (0.65) PTPN1HSD11B1HSD11B2BCHEACHE
Phyllocladene SCHEMBL1006869 0.88 HSD11B1 (0.72) PTPN1HSD11B1HSD11B2BCHEACHE
Phyllocladene SCHEMBL29437839 0.88 HSD11B1 (0.72) PTPN1HSD11B1HSD11B2BCHEACHE
Phyllocladene SCHEMBL29388334 0.88 HSD11B1 (0.72) PTPN1HSD11B1HSD11B2BCHEACHE
Phyllocladene SCHEMBL1006868 0.88 HSD11B1 (0.72) PTPN1HSD11B1HSD11B2BCHEACHE
Kaurenoic Acid SCHEMBL262426 0.79 PTPN1 (1.00) PTPN1HSD11B1HSD11B2BCHEACHE
Kaurenoic Acid SCHEMBL13401813 0.79 PTPN1 (1.00) PTPN1HSD11B1HSD11B2BCHEACHE
Kaurenoic Acid SCHEMBL21803663 0.79 PTPN1 (1.00) PTPN1HSD11B1HSD11B2BCHEACHE
Kaurenoic Acid SCHEMBL3489848 0.79 PTPN1 (1.00) PTPN1HSD11B1HSD11B2BCHEACHE
Kaurenoic Acid SCHEMBL13464128 0.79 PTPN1 (1.00) PTPN1HSD11B1HSD11B2BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4043579-A1 METHOD FOR PREPARING A STEVIOL GLYCOSIDE COMPOSTION DSM IP Assets B.V. (NL) 2022-08-17 EP disclosed
EP-3998337-A1 GERANYLGERANYL PYROPHOSPHATE SYNTHASES DSM IP Assets B.V. (NL) 2022-05-18 EP disclosed
EP-3988653-A2 UDP-GLYCOSYLTRANSFERASES FROM SOLANUM LYCOPERSICUM DSM IP Assets B.V. (NL) 2022-04-27 EP disclosed
EP-3204506-B1 STEVIOL GLYCOSIDE PRODUCTION DSM IP ASSETS BV (NL) 2022-01-12 EP disclosed
EP-3885443-A1 DITERPENE PRODUCTION DSM IP Assets B.V. (NL) 2021-09-29 EP disclosed
EP-3274448-B1 UDP-GLYCOSYLTRANSFERASES FROM SOLANUM LYCOPERSICUM DSM IP ASSETS BV (NL) 2021-08-11 EP disclosed
EP-3862426-A2 UDP-GLYCOSYLTRANSFERASES DSM IP Assets B.V. (NL) 2021-08-11 EP disclosed
EP-3334752-B1 STEVIOL GLYCOSIDE TRANSPORT DSM IP ASSETS BV (NL) 2021-07-07 EP disclosed
WO-2021074344-A1 IMPROVED ISOLATION OF STEVIOL GLYCOSIDES DSM IP ASSETS B.V. (NL) 2021-04-22 WO disclosed
EP-3021689-B1 DITERPENE PRODUCTION DSM IP ASSETS BV (NL) 2021-03-24 EP disclosed
EP-3788059-A1 STEVIOL GLYCOSIDE TRANSPORT DSM IP Assets B.V. (NL) 2021-03-10 EP disclosed
EP-3271457-B1 UDP-GLYCOSYLTRANSFERASES DSM IP ASSETS BV (NL) 2021-01-20 EP disclosed
EP-3718417-A1 STEVIOL GLYCOSIDES DSM IP Assets B.V. (NL) 2020-10-07 EP disclosed
EP-3277829-B1 STEVIOL GLYCOSIDES DSM IP ASSETS BV (NL) 2020-07-08 EP disclosed
EP-3536697-A1 RECOVERY OF STEVIOL GLYCOSIDES DSM IP Assets B.V. (NL) 2019-09-11 EP disclosed
EP-3024941-B1 DITERPENE PRODUCTION IN YARROWIA DSM IP ASSETS BV (NL) 2019-07-03 EP disclosed
EP-3502264-A2 MICROORGANISMS FOR DITERPENE PRODUCTION DSM IP Assets B.V. (NL) 2019-06-26 EP disclosed
EP-3027632-B1 RECOVERY OF STEVIOL GLYCOSIDES FROM A FERMENTATION BROTH DSM IP ASSETS BV (NL) 2019-03-20 EP disclosed
EP-3444338-A1 DITERPENE PRODUCTION DSM IP Assets B.V. (NL) 2019-02-20 EP disclosed
EP-2806754-B1 DITERPENE PRODUCTION DSM IP ASSETS BV (NL) 2018-10-24 EP disclosed